Mette D. Hazenberg1, Sigrid A. Otto1, James W.T. Cohen Stuart2, 3, Martie C.M. Verschuren4, Jan C.C. Borleffs2, Charles A.B. Boucher3, Roel A. Coutinho5, Joep M.A. Lange6, Tobias F. Rinke de Wit7, Aster Tsegaye7, Jacques J.M. van Dongen4, Dörte Hamann1, Rob J. de Boer8
& Frank Miedema1, 91
Department of Clinical Viro-Immunology, CLB, and the Laboratory for Experimental and Clinical Immunology, Academic Medical Center, University of Amsterdam, Plesmanlaan 125, 1066CX, Amsterdam, The Netherlands
2
Department of Internal Medicine, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
3
Department of Virology, Eijkman-Winkler Institute, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
4
Department of Immunology, Erasmus University, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands
5
Department of Public Health and Environment, Municipal Health Service, P.O. Box 2200, 1000 CE, Amsterdam, The Netherlands
6
Division of Infectious Diseases, Tropical medicine and AIDS and the National AIDS Therapy Evaluation Center (NATEC), Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, The Netherlands,
7
Ethiopian-Netherlands AIDS Research Project (ENARP) at the Ethiopian Health and Nutrition Research Institute (EHNRI), P.O. Box 1242, Addis Ababa, Ethiopia
8
Theoretical Biology, Utrecht University, Padualaan 8, 3584 CH, The Netherlands,
9
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Correspondence should be addressed to Frank Miedema F_Miedema@CLB.nl
